Gilead looks to upcoming inflammation, cancer catalysts as pressure to diversify mounts

Trending

• Fierce Biotech4 months ago

  Scientists turn pig semen extract into eye drops that kill cancer in mice

• Uncategorized9 years ago

  These ’90s fashion trends are making a comeback in 2017

• Endpoints News5 months ago

  Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation

• Uncategorized4 months ago

  Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion

• Uncategorized9 years ago

  According to Dior Couture, this taboo fashion accessory is back

• Uncategorized9 years ago

  Steph Curry finally got the contract he deserves from the Warriors